Carl Whatling is a Principal Scientist at AstraZeneca, focusing on translational sciences within early cardiovascular, renal, and metabolic disease. Previously, Carl held various positions at AstraZeneca R&D, including Associate Principal Scientist in bioscience and molecular pharmacology. Carl also completed a BHF post-doctoral fellowship at the Wellcome Trust Centre for Human Genetics at the University of Oxford and served as a Visiting Scientist at Karolinska Institutet. Carl earned a BSc in Microbiology from the University of Leeds and a PhD in Biological Sciences from the University of Birmingham.
This person is not in the org chart
This person is not in any teams
This person is not in any offices